10.21147/j.issn.1000-9604.2017.06.10
Survival difference between EGFR Del19 and L858R mutant advanced non-small cell lung cancer patients receiving gefitinib:a propensity score matching analysis
retrospective cohort study、growth factor receptor、kinase inhibitors、overall survival、the differences、important value、lung cancer
29
TB5;R3
the Beijing Natural Science FoundationCommission 7162038;the Beijing Municipal Administration of Hospitals” Youth ProgramCommission QML20161101
2018-02-06(万方平台首次上网日期,不代表论文的发表时间)
共8页
553-560